• Applied Molecular Plots IPO to Back Transport of Biologic Drugs to Gut

    10 days ago - By Xconomy

    The human gut hosts a hub of activity spanning the immune system, the nervous system, and more. But drugging this nexus comes with challenges. Applied Molecular Transport is developing biologic drugs that use a cell's own mechanisms to get a therapy to a target and the biotech is now planning to tap the public markets to finance more tests of its technology in humans. Applied Molecular set a $100 million goal for its IPO, according to paperwork filed with securities regulators. That figure is expected to change but the South San Francisco-based company needs a capital infusion of some...
    Read more ...